Why the study?
To evaluate healthcare resource utilization and costs associated with rivaroxaban compared with warfarin among nonvalvular atrial fibrillation patients with obesity and polypharmacy.
Does rivaroxaban reduce healthcare resource utilization and costs compared to warfarin in NVAF patients with obesity and polypharmacy?
Does rivaroxaban reduce healthcare resource utilization and costs compared to warfarin in NVAF patients with obesity and polypharmacy?
In patients with NVAF, obesity, and polypharmacy, rivaroxaban use is associated with reduced healthcare resource utilization and lower total medical costs compared to warfarin.
Answers are grounded in this paper and cite their sources.
Rivaroxaban may lower HRU and costs versus warfarin in obese polypharmacy NVAF; leaves open need for prospective confirmation before practice change.
Aim: Evaluate healthcare resource utilization (HRU) and costs associated with rivaroxaban and warfarin among nonvalvular atrial fibrillation (NVAF) patients with obesity and polypharmacy. Materials & methods: IQVIA PharMetrics ® Plus (January 2010–September 2019) data were used to identify NVAF patients with obesity (BMI ≥30 kg/m 2 ) and polypharmacy (≥5 medications) initiated on rivaroxaban or warfarin. Weighted rate ratios and cost differences were evaluated post-treatment initiation. Results: Rivaroxaban was associated with significantly lower rates of HRU, including hospitalization (rate ratio [95% CI]: 0.83 [0.77, 0.92]). Medical costs were reduced in rivaroxaban users (difference [95% CI]: -US$6868 [-US$10,628, -US$2954]), resulting in significantly lower total healthcare costs compared with warfarin users (difference [95% CI]: -US$4433 [-US$8136, -US$582]). Conclusion: Rivaroxaban was associated with lower HRU and costs compared with warfarin among NVAF patients with obesity and polypharmacy in commercially insured US patients.
No takes yet. Share an insight, caveat, or question.
Laliberté et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: